Search research articles
Contact Us
Filters
Showing results (151-160 of 219) with videos related to
Page
of 22
Sort By:
The Journal of Urology
|
September 18, 2009
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy
Yakup Kordan, Sam S Chang, Shady Salem, et al.
The Journal of Urology
|
November 16, 2010
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer
Justin R Gregg, Michael S Cookson, Sharon Phillips, et al.
Prostate Cancer and Prostatic Diseases
|
April 20, 2024
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
Urology
|
April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer
Chad R Ritch, Chaochen You, Alexandra T May, et al.
European Urology
|
January 15, 2013
Screening for bladder cancer: rationale, limitations, whom to target, and perspectives
Stéphane Larré, James W F Catto, Michael S Cookson, et al.
European Urology Oncology
|
December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
Ronald Tutrone, Fred Saad, Daniel J George, et al.
Journal of Endourology
|
June 14, 2003
Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk
D Duane Baldwin, Jennifer A Dunbar, Dipen J Parekh, et al.
The Journal of Urology
|
July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy
Todd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
Prostate Cancer and Prostatic Diseases
|
March 2, 2024
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
BJU International
|
September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Page
of 22
Search research articles
Search
Showing results (151-160 of 219) with videos related to
Sort By:
Page
of 22
The Journal of Urology
|
September 18, 2009
Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy
Yakup Kordan, Sam S Chang, Shady Salem, et al.
The Journal of Urology
|
November 16, 2010
Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer
Justin R Gregg, Michael S Cookson, Sharon Phillips, et al.
Prostate Cancer and Prostatic Diseases
|
April 20, 2024
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
Urology
|
April 22, 2014
Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer
Chad R Ritch, Chaochen You, Alexandra T May, et al.
European Urology
|
January 15, 2013
Screening for bladder cancer: rationale, limitations, whom to target, and perspectives
Stéphane Larré, James W F Catto, Michael S Cookson, et al.
European Urology Oncology
|
December 24, 2023
Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study
Ronald Tutrone, Fred Saad, Daniel J George, et al.
Journal of Endourology
|
June 14, 2003
Single-center comparison of purely laparoscopic, hand-assisted laparoscopic, and open radical nephrectomy in patients at high anesthetic risk
D Duane Baldwin, Jennifer A Dunbar, Dipen J Parekh, et al.
The Journal of Urology
|
July 27, 2011
Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy
Todd M Morgan, Kirk A Keegan, Daniel A Barocas, et al.
Prostate Cancer and Prostatic Diseases
|
March 2, 2024
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
Neal D Shore, Emmanuel S Antonarakis, Ashley E Ross, et al.
BJU International
|
September 11, 2012
ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma
Samuel D Kaffenberger, Todd M Morgan, Kelly L Stratton, et al.
Page
of 22